Etanercept 25mg Injection

Etanercept 25mg Injection is a TNF-blocking biologic used for selected inflammatory joint diseases and plaque psoriasis. It is not interchangeable with every other TNF inhibitor's indications, particularly inflammatory bowel disease.
Administer the prefilled syringe subcutaneously after injection training, using the indication-specific schedule. Rotate sites and avoid bruised, inflamed or damaged skin. Do not shake the syringe or inject any product that has frozen.
The soluble receptor fusion protein binds tumour necrosis factor and limits its interaction with cell-surface receptors involved in inflammation.
Injection-site redness or discomfort, headache and respiratory infections may occur.
Screen for tuberculosis and hepatitis B risk before treatment. Serious infections, demyelinating disease, heart failure and malignancy concerns require assessment; avoid live vaccines during treatment.
Can reduce inflammatory disease activity and improve function in the indicated joint or skin disorder.
TNF blockade can reactivate latent tuberculosis.
No. Do not assume the inflammatory-bowel-disease indications of other TNF inhibitors apply to etanercept.
Contact the treating team promptly; serious infection usually requires interruption and assessment.
No. Shaking can damage the protein preparation.
They should generally be avoided; arrange vaccination planning in advance.
Reactivation is possible and may require specialist monitoring or prevention.
Yes. New or worsening heart failure has been reported.
No. Combining biologic immunosuppressants can substantially increase serious-infection risk.
TNF: tumour necrosis factor, an inflammatory signalling protein. Biologic: a medicine produced using biological systems. Latent tuberculosis: TB infection without active disease symptoms.; AR: Etanercept 25mg حقن; FR: Etanercept 25mg injection; PT: Etanercept 25mg injeção; ES: Etanercept 25mg inyección; RU: Etanercept 25mg инъекция; ID: Etanercept 25mg injeksi; VI: Etanercept 25mg thuốc tiêm; MS: Etanercept 25mg suntikan; TL: Etanercept 25mg iniksyon; ZH-SG: Etanercept 25mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Etanercept 25mg Injection under Immunology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Etanercept 25mg Injection